secwatch / observer
8-K filed February 29, 2024, 6:59 PM ET ticker CC CIK 0001627223
other material confidence high sentiment negative materiality 0.85

Chemours places CEO and CFO on leave; internal review finds potential material weaknesses; delays 10-K

Chemours Co

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Chemours Co reported year ended December 31, 2023 results: revenue approximately $6.0 billion, net income within a range of $(225) million to $(235) million.

Period
year ended December 31, 2023
Revenue
approximately $6.0 billion
Net income
within a range of $(225) million to $(235) million
Result
preliminary results
Exact text from the filing
The Company expects to report net sales of approximately $6.0 billion for the year ended December 31, 2023, compared to net sales of $6.8 billion for the year ended December 31, 2022. The expected decrease was primarily attributable to lower volumes in Titanium Technologies and in Advanced Performance Materials’ Advanced Materials portfolio, partially offset by increased pricing and volumes in Thermal & Specialized Solutions. The Company expects to report net loss attributable to Chemours for the year ended December 31, 2023 within a range of $(225) million to $(235) million, compared to net income attributable to Chemours for the year ended December 31, 2022 of $578 million.
View on SEC.gov

4 earnings releases filed in the last 30 days. Browse all earnings releases →

Chemours Co filing history →

Source: SEC EDGAR
accession 0001193125-24-051940
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.